Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin with Neoadjuvant Chemotherapy in Breast Cancer
NCT04705909Phase 3Unknown
- Sponsor
- Mansoura University
- Start
- Jan 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in breast cancer comparing Pitavastatin Group with Placebo Group (2 arms). Primary endpoints: Clinical Response Rate at 6 months and Relative reduction of Ki67 in tumor samples at 6 months. Status: unknown.
02
Drugs
pitavastatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04705909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04705909.